Trials / Completed
CompletedNCT01920295
Safety and Efficacy of Cryoballoon Ablation of Atrial Fibrillation as First-line Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Yuksek Ihtisas Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Cryoballoon ablation of paroxysmal atrial fibrillation can be used as first-line therapy compared to second choice after failed medical therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cryoballoon ablation |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2013-03-01
- Completion
- 2013-04-01
- First posted
- 2013-08-09
- Last updated
- 2013-08-09
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01920295. Inclusion in this directory is not an endorsement.